Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{166008,
        author = {Smita Nayak and Dhanashri Dhasade and Bhaskar Vaidhun},
        title = {Nanotechnology based therapeutics in lung diseases: An update},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {1},
        pages = {2331-2338},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=166008},
        abstract = {The multidisciplinary field of nanomedicine study incorporates elements of traditional sciences such as chemistry, physics, biology, and materials science. Promising research findings indicate that nanomedicine will radically change medicine through the development of novel approaches to therapeutic agent delivery, vaccine development, and nanotechnology-based medical detections. Lung diseases, encompassing conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and lung cancer, represent a significant global health burden. Traditional therapeutic approaches often face challenges including limited drug efficacy, systemic side effects, and poor targeting. Current approaches to targeting lung diseases involving the relatively new "nanomedicines" have grown significantly during the last decade. It is abundantly clear that the application of nanotechnology in the detection and treatment of lung diseases will modify medical practice sooner rather than later through the development of nanoscale drug delivery systems, diagnostic tools, and regenerative therapies. This review explores the recent advancements in nanotechnology for treating lung diseases, focusing on nanoparticle drug delivery systems as well as cancer and infections of the lung. In conclusion, the integration of nanotechnology in pulmonary therapeutics holds promising potential for improving patient outcomes and revolutionizing the management of lung diseases.},
        keywords = {Nanotechnology, active targeting, lung cancer, tuberculosis.},
        month = {June},
        }